Overall and progression-free survival of patients with metastatic colorectal cancer: A real-world prospective, longitudinal cohort study on the continuum of care (PROMETCO)

被引：0
|
作者：
Koopman, M. [1 ]
Garcia-Carbonero, R. [2 ]
Pinto, C. [3 ]
Mitroshkin, A. [4 ]
Bodoky, G. [5 ]
Mineur, L. [6 ]
Bourgeois, V. [7 ]
Mare, M. [8 ]
Ruiz-Casado, A. [9 ]
Fernandez Montes, A. [10 ]
O'Connor, J. M. R. [11 ]
Sullivan, A. [12 ]
Choucair, E. [13 ]
Sicaire, M. [13 ]
Marti, F. E. [14 ]
Bachet, J-B. [15 ]
机构：
[1] Univ Med Ctr Utrecht, Dept Med Oncol, Utrecht, Netherlands
[2] Dept Med Oncol, Hosp Univ Doce Octubre Imas12, UCM, Madrid, Spain
[3] Clin Canc Ctr Azienda USL, Med Oncol, Reggio Emilia, Italy
[4] Univ Tubingen, Akad Lehrkrankenhaus, Klinikum Freudenstadt, Freudenstadt, Germany
[5] Szent Laszlo Hosp, Dept Oncol, Budapest, Hungary
[6] Inst Canc St Catherine Avignon Provence, GI & Liver Oncol Unit, Avignon, France
[7] Ctr Hosp Boulogne, Oncol Digest, Boulogne Sur Mer, France
[8] Mediterranean Inst Oncol, Med Oncol Unit, Catania, Italy
[9] Univ Hosp Puerta Hierro, Med Oncol, Madrid, Spain
[10] Complexo Hosp Univ Ourense, Dept Med Oncol, Orense, Spain
[11] Inst Alexander Fleming, Dept Clin Oncol, Buenos Aires, DF, Argentina
[12] Servier, Servier Med Affairs, Boston, MA USA
[13] Servier, Servier Med Affairs, Suresnes, France
[14] Christie NHS Fdn Trust, Dept Med Oncol, Manchester, Lancs, England
[15] Sorbonne Univ, Serv Hepatogastroenterol, Paris, France
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1795
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
604P
引用
收藏
页码：S434 / S435
页数：2
相关论文
共 50 条
  • [1] Real-world data on overall and progression-free survival for patients (pts) with metastatic colorectal cancer (mCRC) for the United Kingdom (UK) cohort of the PROMETCO study (PROMETCO-UK)
    Marti, F. E. Marti
    Raman, R.
    Brady, D.
    Walker, G.
    Dewdney, A.
    Lau, S. C.
    Agarwal, R.
    Bridgewater, J. A.
    Lo, N.
    McLeod, D.
    Chauvet, M-A.
    ANNALS OF ONCOLOGY, 2024, 35 : S48 - S48
  • [2] Patient baseline characteristics in the PROMETCO study: A real-world, prospective longitudinal cohort on the continuum of care of metastatic colorectal cancer
    Koopman, M.
    Pinto, C.
    Bodoky, G.
    Marti, F. Marti
    Chrostek, H.
    Raimond-Thibaut, A.
    Fougeray, R.
    Garcia-Carbonero, R.
    Bachet, J.
    ANNALS OF ONCOLOGY, 2021, 32 : S145 - S146
  • [3] Real-world progression-free and overall survival of patients with metastatic colorectal cancer according to first and second-line treatment regimen: PROMETCO study
    Koopman, M.
    Garcia-Carbonero, R.
    Pinto, C.
    Mitroshkin, A.
    Bodoky, G.
    Marti, F. E. Marti
    O'Connor, J. M. R.
    John, S.
    Sgouros, J. I.
    Mansinho, H. F.
    Greil, R.
    Cuyle, P-J.
    Plestina, S.
    Ocvirk, J.
    Sullivan, A.
    Choucair, E.
    Chevallier, B.
    Bachet, J-B.
    ANNALS OF ONCOLOGY, 2024, 35 : S36 - S36
  • [4] Baseline treatment patterns of the first 277 patients in PROMETCO: A real-world, prospective, longitudinal cohort study on the continuum of care in metastatic colorectal cancer (mCRC)
    Bachet, Jean-Baptiste
    Pinto, Carmine
    Bodoky, Gyorgy
    Marti, Francisca Marti
    Mitroshkin, Andrey
    Fazilleau, Marjolaine
    Vermeire, Alice
    Fougeray, Ronan
    Garcia-Carbonero, Rocio
    Koopman, Miriam
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [5] Rationale and design of the PROMETCO study: a real-world, prospective, longitudinal cohort on the continuum of care of metastatic colorectal cancer from a clinical and patient perspective
    Koopman, Miriam
    Pinto, Carmine
    Bodoky, Gyorgy
    Garcia-Carbonero, Rocio
    Marti, Francisca Marti
    Bachet, Jean-Baptiste
    FUTURE ONCOLOGY, 2022, 18 (11) : 1313 - 1320
  • [6] Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic colorectal cancer
    Cicero, Giuseppe
    De Luca, Rossella
    Dieli, Francesco
    ONCOTARGETS AND THERAPY, 2018, 11 : 3059 - 3063
  • [7] REAL-WORLD PROGRESSION-FREE AND OVERALL SURVIVAL OF METASTATIC BREAST CANCER PATIENTS: ANALYSIS OF A NEW GERMAN EMR DATASET
    Wilke, T.
    Dittmar, A.
    Mueller, S.
    Juhl, H.
    VALUE IN HEALTH, 2019, 22 : S535 - S535
  • [8] Bevacizumab Pharmacokinetics Influence Overall and Progression-Free Survival in Metastatic Colorectal Cancer Patients
    Morgane Caulet
    Thierry Lecomte
    Olivier Bouché
    Jérôme Rollin
    Valérie Gouilleux-Gruart
    Nicolas Azzopardi
    Julie Léger
    Christophe Borg
    Jean-Yves Douillard
    Sylvain Manfredi
    Denis Smith
    Olivier Capitain
    Aurélie Ferru
    Driffa Moussata
    Eric Terrebone
    Gilles Paintaud
    David Ternant
    Clinical Pharmacokinetics, 2016, 55 : 1381 - 1394
  • [9] Bevacizumab Pharmacokinetics Influence Overall and Progression-Free Survival in Metastatic Colorectal Cancer Patients
    Caulet, Morgane
    Lecomte, Thierry
    Bouche, Olivier
    Rollin, Jerome
    Gouilleux-Gruart, Valerie
    Azzopardi, Nicolas
    Leger, Julie
    Borg, Christophe
    Douillard, Jean-Yves
    Manfredi, Sylvain
    Smith, Denis
    Capitain, Olivier
    Ferru, Aurelie
    Moussata, Driffa
    Terrebone, Eric
    Paintaud, Gilles
    Ternant, David
    CLINICAL PHARMACOKINETICS, 2016, 55 (11) : 1381 - 1394
  • [10] Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry Data
    Degeling, Koen
    Wong, Hui-Li
    Koffijberg, Hendrik
    Jalali, Azim
    Shapiro, Jeremy
    Kosmider, Suzanne
    Wong, Rachel
    Lee, Belinda
    Burge, Matthew
    Tie, Jeanne
    Yip, Desmond
    Nott, Louise
    Khattak, Adnan
    Lim, Stephanie
    Caird, Susan
    Gibbs, Peter
    IJzerman, Maarten
    PHARMACOECONOMICS, 2020, 38 (11) : 1263 - 1275
12345